Arachidonic acid of platelet phospholipids is decreased after extracorporeal removal of plasma low density lipoproteins in patients with familial hypercholesterolemia

Atherosclerosis

Volumn 131, Issue 1, 1997, Pages 97-106

  Bräutigam, Robert ^a   Bräutigam, Carola ^a   Lorenz, Reinhard ^a   Richter, Werner O ^b   Engelmann, Bernd ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Alkenylacyl (plasmalogen) phosphatidylcholine; Diacyl phosphatidylethanolamine; Immunoabsorption; Linoleic acid; Oleic acid

Indexed keywords

ARACHIDONIC ACID; LINOLEIC ACID; LOW DENSITY LIPOPROTEIN; OLEIC ACID; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE; PHOSPHOLIPID; PLASMALOGEN;

ADULT; AGED; APHERESIS; ARACHIDONIC ACID METABOLISM; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; FAMILIAL HYPERCHOLESTEROLEMIA; HUMAN; IMMUNOADSORPTION; MALE; PRIORITY JOURNAL; THROMBOCYTE;

ADULT; ARACHIDONIC ACID; BLOOD COMPONENT REMOVAL; BLOOD PLATELETS; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; IMMUNOSORBENT TECHNIQUES; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; PHOSPHOLIPIDS; THROMBOXANE A2; THROMBOXANE B2;

EID: 0343472086     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(97)06087-5     Document Type: Article

References (29)

1. Nozawa Y, Nakashima S, Nagata K. Phospholipid-mediated signaling in receptor activation of human platelets. Biochim Biophys Acta 1991;1082:219.
2. Surya II, Akkerman JWN. The influence of lipoproteins on blood platelets. Am Heart J 1993;125:272.
3. Spector AA, Hoak JC, Warner ED. Utilization of long-chain free fatty acids by human platelets. J Clin Inv 1970;49:1489.
4. Surya II, Gorter G, Akkerman JWN. Arachidonate transfer between platelets and lipoproteins. Thromb Haemost 1992;6:719.
5. Bereziat G, Chambaz J, Trugnan G, Pepin D, Polonovski J. Turnover of phospholipid linoleic and arachidonic acid in human platelets from plasma lecithins. J Lipid Res 1978;19:495.
6. Engelmann B, Kögl C, Kulschar R, Schaipp B. Transfer of phosphatidylcholine, phosphatidylethanolamine and sphingomyelin from low and high density lipoproteins to human platelets. Biochem J 1996;315:781.
7. Hochgraf E, Levy Y, Aviram M, Brook JG, Cogan U. Lovastatin decreases plasma and platelet cholesterol levels and normalizes elevated platelet fluidity and aggregation in hypercholesterolemic patients. Metabolism 1994;43:11.
8. Mosconi C, Colli S, Tremoli E, Galli C. Phosphatidylinositol (PI) and PI-associated arachidonate are elevated in platelet total membranes from type II hypercholesterolemic subjects. Atherosclerosis 1988;72:129.
9. Chetty N, Naran NH. Platelet hyperreactivity in hyperlipidemia with specific reference to platelet lipids and fatty acid composition. Clin Chim Acta 1992;213:1.
10. Davi G, Averna M, Catalano I et al. Increased thromboxane biosynthesis in type IIa hypercholesterolemia. Circulation 1992;85:1792.
11. Richter WO, Jacob BG, Ritter MM, Sühler K, Vierneisel K, Schwandt P. Three-year treatment of familial heterozygous hypercholesterolemia by extracorporeal low-density lipoprotein immunoadsorption with polyclonal apolipoprotein B antibodies. Metabolism 1993;7:888.
12. Lorenz RL, Uedelhoven WM, Fischer S, Ruetzel A, Weber PC. A critical evaluation of urinary immunoreactive thromboxane: feasibility of its determination as a potential vascular risk indicator. Biochim Biophys Acta 1989;993:259.
13. Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 1959;37:912.
14. Engelmann B, Streich S, Schönthier UM, Richter WO, Duhm J. Changes of membrane phospholipid composition of human erythrocytes in hyperlipidemias. I. Increased phosphatidylcholine and reduced sphingomyelin in patients with elevated levels of triacylglycerol-rich lipoproteins. Biochim Biophys Acta 1992;1165:32.
15. Kulschar R, Engelmann B, Bräutigam C, Duhm J, Thiery J, Richter WO. Fast transmission of alterations in plasma phosphatidylcholine/sphingomyelin ratio and lyso phosphatidylcholine levels into changes of red blood cell membrane phospholipid composition after low density lipoprotein apheresis. Eur J Clin Invest 1995;25:258.
16. Bräutigam C, Engelmann B, Reiss D et al. Plasmalogen phospholipids in plasma lipoproteins of normolipidemic donors and patients with hypercholesterolemia treated by LDL apheresis. Atherosclerosis 1996;119:77.
17. + countertransport: in vivo and in vitro evidence. J Membrane Biol 1993;133:99.
18. Engelmann B, Bräutigam C, Kulschar R et al. Reversible reduction of phospholipid bound arachidonic acid after low density lipoprotein apheresis. Evidence for rapid incorporation of plasmalogen phosphatidylethanolamine into the red blood cell membrane. Biochim Biophys Acta 1994;1196:154.
19. Arvidson GAE. Structural and metabolic heterogeneity of rat liver glycerophosphatides. Eur J Biochem 1968;4:478.
20. Takamura H, Narita H, Park HJ, Tanaka K-I, Matsuura T, Kito M. Differential hydrolysis of phospholipid molecular species during activation of human platelets with thrombin and collagen. J Biol Chem 1987;262:2262.
21. Skipski VP. In: GJ Nelson (ed). Blood Lipids and Lipoproteins: Quantification, Composition and Metabolism. New York: Wiley, 1975;471-583.
22. Schick B, Schick PK. The effect of hypercholesterolemia on guinea pig platelets, erythrocytes and megakaryocytes. Biochim Biophys Acta 1985;833:291.
23. Dalal KB, Ebbe S, Mazoyer E, Carpenter D, Yee T. Biochemical and functional abnormalities in hypercholesterolemic rabbit platelets. Lipids 1990;25:86.
24. Habenicht AJR, Salbach P, Görig M et al. The LDL receptor pathway delivers arachidonic acid for eicosanoid formation in cells stimulated by platelet-derived growth factor. Nature 1990;345:634.
25. Landolfi R, De Candia E, Rocca B et al. Effects of unfractionated and low molecular weight heparin on platelet thromboxane biosynthesis 'in vivo'. Thromb Haemost 1994;72:942.
26. 2 in thrombin-stimulated human platelets. Biochim Biophys Acta 1987;920:205.
27. Colard O, Breton M, Pepin D, Chevy F, Bereziat G, Polonovski J. Arachidonate cannot be released directly from diacyl-sn-glyc-ero-3-phosphocholine in thrombin-stimulated platelets. Biochem J 1989;259:333.
28. Brook G, Winterstein G, Aviram M. Platelet function and lipoprotein levels after plasma-exchange in patients with familial hypercholesterolemia. Clin Sci 1983;64:637.
29. Bröijersen A, Eriksson M, Larsson PT, Beck O, Berglund L, Angelin B. Effects of selective LDL-apheresis and pravastatin therapy on platelet function in familial hypercholesterolemia. Eur J Clin Invest 1994;24:488.